Myriad Genetics Inc (MYGN)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2020	Jun 30, 2019
Operating income	US$ in thousands	-257,400	-140,600	-190,500	-231,700	7,600
Total assets	US$ in thousands	1,146,500	1,198,700	1,320,700	1,404,600	1,562,700
Operating ROA		-22.45%	-11.73%	-14.42%	-16.50%	0.49%

December 31, 2023 calculation

Operating ROA = Operating income ÷ Total assets
= $-257,400K ÷ $1,146,500K
= -22.45%

Myriad Genetics, Inc.'s operating return on assets (operating ROA) has shown a decreasing trend over the past five periods, from 0.56% as of June 30, 2019, to -12.61% as of December 31, 2023. This suggests that the company's ability to generate operating earnings from its assets has deteriorated significantly over this time frame.

A negative operating ROA indicates that the company is generating operating losses relative to its assets, which could be a concerning sign for investors and stakeholders. It may suggest inefficiencies in utilizing the company's assets to generate profits from its core operations.

The consistent decline in operating ROA points towards potential operational challenges or inefficiencies within Myriad Genetics, Inc. It is crucial for the company to address these issues and improve its operating performance to enhance shareholder value and ensure sustainable growth in the future.